The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCPT.L Regulatory News (CPT)

  • There is currently no data for CPT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Circular

8 Jul 2016 17:00

RNS Number : 7100D
Frontier Resources International
08 July 2016
 

Frontier Resources International Plc

("Frontier" or the "Company")

8 July 2016

Issue of Circular

The Board of Frontier (AIM Ticker: FRI) announces that the Company has today issued a circular convening a general meeting for 11.15am on Monday 25 July.

As previously announced on 7 July 2016, the Company) intends to tidy up its share capital by buying back all the deferred shares of 0.9p each and A deferred shares of 0.09p each in its share capital ("Deferred Shares") for the sum of £1 in aggregate ("Buy-Back"). 

The Deferred Shares were created because, due to earlier losses of capital, the market value of the Company's ordinary shares had dropped below their nominal value and, as company law does not permit a public limited company to issue shares at less than their nominal value, the Company could not raise new funding by the allotment of new ordinary shares. In order to enable the Company to issue new shares the nominal value of such ordinary shares was rebased and the excess share capital was applied in creating the Deferred Shares.

Under the terms of its articles of association ("Articles") the Company is entitled to buy back all of the Deferred Shares for £1 in aggregate. No shareholder is entitled to be paid any sum if the proceeds of sale of his Deferred Shares are less than 1p, and the Company does not anticipate any holder of Deferred Shares qualifying to receive any such proceeds. The Buy-Back has to be funded from the carried forward profits of the Company or a fresh issue of shares. As the Company does not have any carried forward profits, the Company has allotted 3,721 Ordinary Shares of 0.01p each at an issue price of 0.03p per Ordinary Share to Barbara Spurrier, one of its directors, in order to create the necessary proceeds to effect the Buy-Back. Once the Buy-Back has been completed the Deferred Shares will be cancelled, and the Ordinary Shares will constitute the only class of share capital in the Company.

Any Director of the Company is authorised under the Articles to execute a contract to effect the Buy-Back on behalf of all the holders of the Deferred Shares (the "Contract"). The Contract has to be approved by a special resolution of the ordinary shareholders of the Company. Under the Articles the Company is not required to seek the approval for the Buy-Back from the holders of the Deferred Shares. A copy of the Contract is on display at the Company's website at http://www.friplc.com/ and will remain on display for ten years from the date that the purchase of the Deferred Shares is completed.

The Company has convened a general meeting of the Company to be held at 11.15 a.m. on 25 July 2016 at Finsgate, 5-7 Cranwood Street, London EC1V 9EE, at which a special resolution to approve the Buy-Back and the Contract will be proposed ("General Meeting").

The board of directors of the Company is of the opinion that the above resolution to be proposed at the General Meeting (the "Resolution") is in the best interests of the Company and its shareholders as a whole. Accordingly, the Directors unanimously recommend that shareholders vote in favour of the Resolution, as the Directors intend to do in respect of their own beneficial shareholdings, which amount in aggregate to 537,097,355 ordinary shares of 0.03p each, representing approximately 10.41 per cent. of the existing ordinary share capital of the Company.

Enquiries:

Frontier Resources International Plc

Adam Reynolds, Chairman

Tel: +44 (0) 7785 908158

 

SPARK Advisory Partners Limited (Nomad)

Neil Baldwin/Mark Brady

Tel: +44 (0)20 368 3550

 

Beaufort Securities Limited (Broker) 

Jon Belliss

Tel: +44 (0)20 7382 8300

Yellow Jersey PR Limited (Financial PR)

Felicity Winkles/ Joe Burgess/ Josh Cole

Tel: +44 (0) 7748 843 871

 

A copy of this announcement is available from the Company's website www.friplc.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLVLFBQDFZBBD
Date   Source Headline
2nd Dec 20204:25 pmRNSChange of name to MyHealthChecked Plc
2nd Dec 202011:06 amRNSSecond Price Monitoring Extn
2nd Dec 202011:01 amRNSPrice Monitoring Extension
2nd Dec 20207:00 amRNSGenomic testing service launch and Change of name
24th Nov 20204:41 pmRNSSecond Price Monitoring Extn
24th Nov 20204:36 pmRNSPrice Monitoring Extension
23rd Nov 20207:00 amRNSAcquisition of home-use genetic testing company
28th Sep 20207:00 amRNSHalf-year Report
22nd Jul 20207:00 amRNSChange of Adviser
6th Jul 20207:00 amRNSCommercial update; Change of registered office
2nd Jul 20203:24 pmRNSResult of AGM
5th Jun 20207:01 amRNSDirector/PDMR Shareholding
5th Jun 20207:00 amRNSNotice of Annual General Meeting
2nd Jun 20207:00 amRNSCommercial update
29th May 20207:00 amRNSFinal Results
4th May 20207:00 amRNSPartnership agreement with Abingdon Health
27th Apr 20208:16 amRNSDirector/PDMR Shareholding
24th Apr 202011:26 amRNSResult of GM & Completion of Fundraise
14th Apr 20209:27 amRNSHolding(s) in Company
14th Apr 20207:00 amRNSManufacturing outsourcing agreements for myLotus®
8th Apr 20207:00 amRNSPlacing and Subscription to raise £1.9 million
29th Jan 20207:00 amRNSTrading Update
14th Nov 20197:00 amRNSBoard Appointments
13th Nov 20198:35 amRNSBoard changes - replacement
13th Nov 20197:00 amRNSBoard Changes
31st Oct 20197:00 amRNSConcepta announces first myLotus® UK birth
25th Oct 20197:00 amRNSBoard Changes
30th Sep 20197:00 amRNSInterim Results
30th Sep 20197:00 amRNSFirst myLotus® UK Fertility Clinic collaboration
29th Jul 20197:00 amRNSGrant of Options
9th Jul 20197:00 amRNSmyLotus® pregnancies in double figures
13th Jun 20192:01 pmRNSResult of AGM
21st May 20199:00 amRNSNotice of AGM
14th May 20197:01 amRNSAnnual Results
14th May 20197:00 amRNSConcepta announces first myLotus® pregnancies
30th Apr 20194:28 pmRNSHolding(s) in Company
30th Apr 20191:46 pmRNSTR-1: form for notification of major holdings
29th Apr 20191:20 pmRNSTR-1: notification of major holdings
26th Apr 201910:52 amRNSDirector/PDMR Shareholding
8th Apr 20197:00 amRNSPlacing to raise £2.3m; Notice of General Meeting
29th Mar 20197:00 amRNSConcepta to supply myLotus® to Boots UK
12th Mar 20197:00 amRNSConcepta to supply myLotus® to Walgreens Boots
17th Dec 20187:00 amRNSmyLotus® successful UK launch
31st Oct 20187:00 amRNSmyLotus® launch at The Fertility Show, London
29th Oct 20187:00 amRNSmyLotus gains CE-mark regulatory approval
5th Oct 20182:42 pmRNSHolding(s) in Company
28th Sep 20187:00 amRNSGrant of Options
27th Sep 20184:41 pmRNSSecond Price Monitoring Extn
27th Sep 20184:37 pmRNSPrice Monitoring Extension
27th Sep 20187:01 amRNSDirectorate change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.